Use of a combination of pentoxifylline with type I interferons to treat multiple sclerosis
DE19514048A1
Trapidil for use in the therapy of immunomodulatory diseases
WO9620707A1
Pharmaceutical preparations containing nifedipine and process for producing it
DE4416674A1
Topical preparation containing acyclovir
HU9503019D0
New cyclosporine-containing pharmaceutical compositions for oral administration
DE4412201A1
New pharmaceutical preparations for oral administration containing cyclosporin
DE4402867C1
Liposome(s) contg. encapsulated protein for pharmaceutical or cosmetic use
DE4343034C1
Use of pentoxifylline for the treatment of multiple sclerosis
DE4332041A1
Use of pentoxifylline in certain lung diseases
DE3829398A1
FIXED MEDICINAL COMBINATION WITH DELAYED RELEASE
DE3710216A1
USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR LOCAL TREATMENT OF TROPHIC DISORDERS
DE3636123A1
ORAL ADMINISTRATIVE PREPARATIONS CONTAINING SINGLE DOSE FROM 10 TO 240 MG DIHYDROPYRIDINE
DE3604149A1
COMBINATION OF MEDICINAL PRODUCTS
DE3440864A1
Process for the stabilisation of camomile extracts and their constituents
DE3438830A1
PHARMACEUTICAL FORM CONTAINING NIFEDIPIN AND METHOD FOR THE PRODUCTION THEREOF
DE3421468A1
LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE
DE3326167A1
Solid drug forms which contain as active ingredient N-4-[2- (5-chloro-2-methoxybenzamido)ethyl]phenylsulphonyl-N'-cyclohexylurea, and process for the production thereof
DE3325652A1
Solid, stable pharmaceutical formulations containing isosorbide 5-mononitrate, and process for the production thereof
DE3228384A1
Method for improving the solubility of a sulphonylurea derivative and pharmaceutical compositions containing the latter
